Interactions of ketoprofen and ibuprofen with β-cyclodextrins in solution and in the solid state
暂无分享,去创建一个
Paola Mura | P. Mura | Milena Sorrenti | M. T Faucci | A. Manderioli | G Bramanti | M. Faucci | G. P. Bettinetti | M. Sorrenti | A. Manderioli | G. Bramanti | G. Bettinetti
[1] T. Higuchi,et al. Phase solubility techniques , 1965 .
[2] T. Nagai,et al. Inclusion compounds of non-steroidal antiinflammatory and other slightly water soluble drugs with alpha- and beta-cyclodextrins in powdered form. , 1975, Chemical & pharmaceutical bulletin.
[3] K. Terada,et al. Interaction of tri-O-methyl-β-cyclodextrin with drugs , 1984 .
[4] C. Hansch,et al. A NEW SUBSTITUENT CONSTANT, PI, DERIVED FROM PARTITION COEFFICIENTS , 1964 .
[5] V. Zecchi,et al. Inclusion complexes between non steroidal antiinflammatory drugs and β-cyclodextrin , 1991 .
[6] C. Rhodes,et al. Stereochemical Aspects of the Molecular Pharmaceutics of Ibuprofen , 1993, The Journal of pharmacy and pharmacology.
[7] Kennath A. Connors. Cyclodextrins and their industrial uses: Dominique Duchêne (Editor), Editions de Santé, 19 rue Louis-le-Grand, 75002 Paris, France, 1987, 448 pages, ISBN 2-86411-019-9. , 1988 .
[8] V. Zecchi,et al. Dissolution and partition thermodynamic functions of some nonsteroidal anti-inflammatory drugs. , 1986, Journal of pharmaceutical sciences.
[9] Andrea Gazzaniga,et al. Thermal behaviour and dissolution properties of naproxen in combinations with chemically modified ß-Cyclodextrins , 1992 .
[10] K. H. Kim,et al. Application of differential scanning calorimetry to the study of solid drug dispersions. , 1985, Journal of pharmaceutical sciences.
[11] K. A. Khan. The concept of dissolution efficiency , 1975, The Journal of pharmacy and pharmacology.
[12] Maurice R. Eftink,et al. Cyclodextrin-adamantanecarboxylate inclusion complexes: studies of the variation in cavity size , 1985 .
[13] Fabrizio Melani,et al. Carbon-13 Nuclear Magnetic Resonance Study of Naproxen Interaction with Cyciodextrins in Solution , 1991 .
[14] T. Imai,et al. [Stabilization and reduction of irritant taste of anti-inflammatory drug pirprofen by beta-cyclodextrin complexation]. , 1984, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[15] O. Corrigan,et al. Mechanism of drug dissolution rate enhancement from β‐cyclodextrin‐drug systems , 1982 .
[16] K. Uekama,et al. Enhancing effects of cyclodextrins on nasal absorption of insulin in rats , 1992 .
[17] A. Karara,et al. Characterization, dissolution and bioavailability in rats of ibuprofen-β-cyclodextrin complex system , 1986 .
[18] G. Giammona,et al. Comparative study on Inclusion compounds of 4-Biphenylacetic acid with β-Cyclodextrin, Hydroxypropylated-β-Cyclodextrins, and methylated-β-Cyclodextrins , 1994 .
[19] L. M. Schwartz,et al. Complexation of 4-biphenylcarboxylate by cyclohexaamylose. A conductometric and carbon-13 nuclear magnetic resonance spectrometric analysis , 1978 .
[20] J. Guillory,et al. Heptakis(2,6-di-O-methyl)-beta-cyclodextrin complexation with the antitumor agent chlorambucil. , 1989, Journal of pharmaceutical sciences.
[21] Y. Sasaki,et al. Inclusion compounds of cyclodextrin and azo dyes. IV(b): Nuclear magnetic resonance and circular dichroism spectra of γ-cyclodextrin and orange II in the solution state , 1984 .
[22] V. Zecchi,et al. Availability of NSAIDH β‐Cyclodextrin Inclusion Complexes , 1989 .
[23] K. Uekama,et al. Pharmaceutical evaluation of hydroxyalkyl ethers of β-cyclodextrins , 1988 .
[24] R. Kümmel,et al. Dissociation constants, solubilities and dissolution rates of some selected nonsteroidal antiinflammatories , 1983 .
[25] A. Chiarini,et al. pH‐Solubility Relationship and Partition Coefficients for some Anti‐Inflammatory Arylaliphatic Acids , 1984 .